MSL
KYNB

Mackay Shields LLC’s Kyntra Bio KYNB Stock Holding History

Mackay Shields LLC’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,666
Closed -$1.45M – 922
2021
Q1 		$1.45M Sell
1,666
-822
-33% -$875K 0.01% 891
2020
Q4 		$2.31M Sell
2,488
-88
-3% -$92.5K 0.02% 798
2020
Q3 		$2.65M Sell
2,576
-208
-7% -$224K 0.02% 667
2020
Q2 		$2.82M Buy
2,784
+456
+20% +$423K 0.02% 606
2020
Q1 		$2.02M Buy
2,328
+88
+4% +$87.5K 0.02% 661
2019
Q4 		$2.4M Sell
2,240
-84
-4% -$85.8K 0.02% 796
2019
Q3 		$2.15M Sell
2,324
-44
-2% -$48.3K 0.01% 868
2019
Q2 		$2.67M Buy
2,368
+1,434
+154% +$1.57M 0.02% 787
2019
Q1 		$1.27M Sell
934
-12
-1% -$16.3K 0.01% 914
2018
Q4 		$1.09M Sell
946
-202
-18% -$227K 0.01% 905
2018
Q3 		$1.74M Buy
1,148
+236
+26% +$363K 0.01% 742
2018
Q2 		$1.43M Sell
912
-24
-3% -$31.3K 0.01% 866
2018
Q1 		$1.08M Buy
+936
New +$1.23M 0.01% 966

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mackay Shields LLC's KYNB Position: Q2 2021 in Review

Mackay Shields LLC sold out of Kyntra Bio (KYNB) in Q2 2021, closing a stake of 1,666 shares — an estimated $1.45M sold.

Mackay Shields LLC first reported a position in KYNB in Q1 2018 and held it in 13 quarters. The position peaked at $2.82M in Q2 2020. 174 funds tracked by Wall St. Rank hold KYNB as of Q2 2021.

  • Mackay Shields LLC reported no remaining Kyntra Bio position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 1,666 Kyntra Bio shares in Q2 2021, an estimated $1.45M.
  • Mackay Shields LLC first reported a position in Kyntra Bio in Q1 2018 and held it in 13 quarters.
  • Mackay Shields LLC's Kyntra Bio position peaked at $2.82M in Q2 2020.
  • 174 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.